Sodium Valproate + Valproic Acid Solution bulk supplier for pharma manufacturers

Sodium Valproate + Valproic Acid Solution 200 mg/5 mL, 250 mg/5 mL Suppliers & Bulk Manufacturers

Available Forms: Oral Solution/Syrup

Available Strengths: 200 mg/5 mL, 250 mg/5 mL

Reference Brands: Depakote(US), Epilim Chrono(EU)

Sodium Valproate + Valproic Acid is a key treatment for epilepsy and bipolar disorder, available in oral and IV forms. With global brands like Epilim Chrono and Depakote, it’s a high-demand neuropsychiatric product. Pharma B2B buyers source this from GMP-approved manufacturers for international markets.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Sodium Valproate + Valproic Acid combination is widely prescribed for the management of epilepsy, bipolar disorder, and migraine prophylaxis. This dual formulation ensures rapid and sustained release, improving therapeutic outcomes. Available in oral (200 mg, 300 mg, 500 mg) and injectable forms (100 mg/mL), it is marketed under popular brands like Epilim Chrono in the EU and Depakote equivalents in the US. Pharmaceutical exporters and distributors globally source this product from GMP-certified manufacturers due to its proven efficacy and consistent market demand. Ideal for neuropsychiatric B2B portfolios, it offers stable market opportunities for generics and branded suppliers.

Sodium Valproate + Valproic Acid Solution — third party manufacturing & bulk supply

Sodium Valproate + Valproic Acid Solution 200 mg/5 mL, 250 mg/5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sodium Valproate + Valproic Acid Solution is supplied as Oral Solution/Syrup — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sodium Valproate + Valproic Acid Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sodium Valproate + Valproic Acid Solutio... →

Back to Listing

Frequently Asked Questions

It is used to treat epilepsy, including generalized, focal, and absence seizures, as well as for mood stabilization in bipolar disorder and prevention of migraine headaches. The liquid formulation allows flexible dosing for patients of different ages and weights.

The oral solution contains sodium valproate or valproic acid as the active ingredient. It works by increasing gamma-aminobutyric acid (GABA) levels in the brain, which helps calm overactive nerve activity responsible for seizures and mood swings.

Common trade names include Epival Oral Solution and Depakine Syrup.

It is manufactured by several pharmaceutical companies globally, including Abbott Laboratories and Sanofi, along with other regional generic manufacturers.

The generic names are sodium valproate and valproic acid.

Brand names include Epival Oral Solution and Depakine Syrup.

It is manufactured in countries including the United States, European Union nations, India, and other regulated pharmaceutical hubs that produce antiepileptic medicines under approved quality standards.